Pharmafile Logo

Clinial Trials

AstraZeneca AZ

AZ CEO says company’s renaissance is on track

Soriot insists AZ’s strategy is working and will continue

Magic of Lucid targets rare and specialist diseases

Lucid Group, the award-winning global medical communications company with offices in London, Buckinghamshire, Macclesfield and New York, has announced the launch of a new agency specialising in rare and specialist...

Lucid Group Communications Limited

- PMLiVE

Pharma’s coral reef

Who competes with whom has changed, which means how to compete must change too

- PMLiVE

Pulling together

Making sense of the present and future environment for the life science sector in the UK

- PMLiVE

Double promotion for Porterhouse Medical’s incredible creatives

Porterhouse Medical celebrates the great news of a double promotion in their creative team, as Mat and Dan have been promoted to middleweight designers with immediate effect.Mat has now been...

Porterhouse Medical Group

- PMLiVE

Novartis raises pressure in Pfizer’s Ibrance with new Kisqali data

Women on Kisqali were found to have a longer PFS than those on hormonal therapy alone

Bristol-Myers Squibb (BMS) building

BMS adds another EU indication to Opdivo’s growing list

Wins European licence to treat high-risk advanced melanoma

- PMLiVE

GSK to replace R&D head Vallance with Calico’s Hal Barron

Barron will also hold an executive director position on GSK’s board

- PMLiVE

Novartis strengthens autoimmune indications for Cosentyx

Data shows its IL-17A inhibitor can reduce structural disease progression

- PMLiVE

MorphoSys appoints Dr Markus Enzelberger as CSO

He succeeds Dr Marlies Sproll who resigns

- PMLiVE

Revolutionising how healthcare is delivered

The big technology shift sweeping the global connection of healthcare

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links